SusanLBaldwinMD

PubMed

• 69 citations
  The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
  Susan L. Baldwin, Sasha E Larsen, Diane J. Ordway, Gail H. Cassell, Rhea N. Coler> ;Plos Neglected Tropical Diseases. 2019 Feb 14
• 32 citations
  The adjuvant GLA-AF enhances human intradermal vaccine responses
  Darrick Carter, Neal Van Hoeven, Susan L. Baldwin, Yotam Levin, Efrat Kochba, Al Magill, Nathalie Charland, Nathalie Landry, Khin Nu, Aude Frevol, Jill A. Ashman, Zach...> ;Science Advances. 2018 Sep 1
• 19 citations
  Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
  Susan L. Baldwin, Fan Chi Hsu, Neal Van Hoeven, Emily Gage, Brian Granger, Jeffrey A. Guderian, Sasha E Larsen, Erica C. Lorenzo, Laura Haynes, Steven G. Reed, Rhea N....> ;Frontiers in Immunology. 2018 Feb 19
• 19 citations
  Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.
  James D. Allen, Simon O. Owino, Donald M. Carter, Corey J. Crevar, Valerie A. Reese, Christopher B. Fox, Rhea N. Coler, Steven G. Reed, Susan L. Baldwin, Ted M. Ross> ;Vaccine. 2017 Sep 12
• 62 citations
  A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.
  Neal Van Hoeven, Christopher B. Fox, Brian Granger, Tara Evers, Sharvari W Joshi, Ghislain I. Nana, Sarah C Evans, Susan Lin, Hong Liang, Li Liang, Rie Nakajima, Phili...> ;Scientific Reports. 2017 Apr 21
• 14 citations
  Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.
  Natasha Dubois Cauwelaert, Susan L. Baldwin, Mark T. Orr, Anthony L. Desbien, Emily Gage, Kimberly A. Hofmeyer, Rhea N. Coler> ;European Journal of Immunology. 2016 Oct 1
• 28 citations
  Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen
  Susan L. Baldwin, Will Roeffen, Susheel K. Singh, Régis Wendpayangde Tiendrebeogo, Michael Christiansen, Elyse A. Beebe, Darrick Carter, Christopher B. Fox, Randall F....> ;Vaccine. 2016 Apr 27
• 12 citations
  Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inacti...
  Crina Stavaru, Adrian Onu, Emilia Lupulescu, Catalin Tucureanu, Orhan Rasid, Ene Vlase, Cristin Coman, Iuliana Caras, Alina Ghiorghisor, Laurentiu Berbecila, Vlad Tofa...> ;Human Vaccines & Immunotherapeutics. 2016 Apr 2
• 23 citations
  A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
  Neal Van Hoeven, Sharvari W Joshi, Ghislain I. Nana, Angela M. Bosco-Lauth, Christopher B. Fox, Richard A. Bowen, David E. Clements, Timothy Martyak, D. Elliot Parks, ...> ;Plos One. 2016 Feb 22
• 36 citations
  Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate
  Susan L. Baldwin, Valerie A. Reese, Po-Wei D. Huang, Elyse A. Beebe, Brendan K. Podell, Steven G. Reed, Rhea N. Coler> ;Clinical and Vaccine Immunology. 2016 Feb 1
• 13 citations
  The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivative.
  Susan L. Baldwin, Valerie A. Reese, Brian Granger, Mark T. Orr, Gregory C. Ireton, Rhea N. Coler, Steven G. Reed> ;Clinical and Vaccine Immunology. 2014 Sep 1
• 8 citations
  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis
  Crystal A. Shanley, Gregory C. Ireton, Susan L. Baldwin, Rhea N. Coler, Steven G. Reed, Randall J. Basaraba, Ian M. Orme> ;Tuberculosis. 2014 Mar 1
• 87 citations
  Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
  Mark T. Orr, Christopher B. Fox, Susan L. Baldwin, Sandra J. Sivananthan, Elyse Lucas, Susan Lin, Tony Phan, James J. Moon, Thomas S. Vedvick, Steven G. Reed, Rhea N. ...> ;Journal of Controlled Release. 2013 Nov 28
• 13 citations
  Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle
  Gareth Jones, Sabine Steinbach, Derek Clifford, Susan L. Baldwin, Gregory C. Ireton, Rhea N. Coler, Steven G. Reed, H. Martin Vordermeier> ;Vaccine. 2013 Oct 25
• 24 citations
  Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells
  Susan L. Baldwin, Lance K. Ching, Samuel O. Pine, Magdalini Moutaftsi, Elyse Lucas, Aarthy C. Vallur, Mark T. Orr, Sylvie Bertholet, Steven G. Reed, Rhea N. Coler> ;Journal of Immunology. 2013 Sep 1
• 21 citations
  Clinical vaccine development for H5N1 influenza
  Christopher H. Clegg, Joseph A. Rininger, Susan L. Baldwin> ;Expert Review of Vaccines. 2013 Jul 1
• 30 citations
  Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults
  Janet E. McElhaney, Rhea N. Coler, Susan L. Baldwin> ;Expert Review of Vaccines. 2013 Jul 1
• 22 citations
  Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses
  Anthony L. Desbien, Neal Van Hoeven, Steven J. Reed, Allen Casey, John D. Laurance, Susan L. Baldwin, Malcolm S. Duthie, Steven G. Reed, Darrick Carter> ;Biotechniques. 2013 Jun 1
• 17 citations
  Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
  Christopher B. Fox, Lucien Barnes, Tara Evers, James Chesko, Thomas S. Vedvick, Rhea N. Coler, Steven G. Reed, Susan L. Baldwin> ;Influenza and Other Respiratory Viruses. 2013 Sep 1
• 59 citations
  Adjuvant solution for pandemic influenza vaccine production
  Christopher H. Clegg, Richard Roque, Neal Van Hoeven, Lucy A. Perrone, Susan L. Baldwin, Joseph A. Rininger, Richard A. Bowen, Steven G. Reed> ;Proceedings of the National Academy of Sciences of the United States of America. 2012 Oct 23
• 42 citations
  Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines
  Christopher B. Fox, Susan L. Baldwin, Thomas S. Vedvick, Evelina Angov, Steven G. Reed> ;Clinical and Vaccine Immunology. 2012 Oct 1
• 74 citations
  Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
  Rhea N. Coler, Sylvie Bertholet, Samuel O. Pine, Mark T. Orr, Valerie A. Reese, Hillarie Plessner Windish, Charles Davis, Maria Kahn, Susan L. Baldwin, Steven G. Reed> ;The Journal of Infectious Diseases. 2013 Apr 15
• 19 citations
  Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
  Christopher B. Fox, Susan L. Baldwin, Malcolm S. Duthie, Steven G. Reed, Thomas S. Vedvick> ;AAPS Pharmscitech. 2012 Mar 14
• 88 citations
  The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
  Susan L. Baldwin, Sylvie Bertholet, Valerie A. Reese, Lance K. Ching, Steven G. Reed, Rhea N. Coler> ;Journal of Immunology. 2012 Mar 1
• 53 citations
  Immunomodulatory and Physical Effects of Oil Composition in Vaccine Adjuvant Emulsions
  Christopher B. Fox, Susan L. Baldwin, Malcolm S. Duthie, Steven G. Reed, Thomas S. Vedvick> ;Vaccine. 2011 Nov 28
• Join now to see all